
FDA authorises IQOS marketing as modified risk tobacco product
Decision ensures users can make informed switch to IQOS as better choice to smoking
Decision ensures users can make informed switch to IQOS as better choice to smoking
PMI is bringing IQOS to the U.S. market through an exclusive lisensing agreement with Altria Group, Inc. We are confident Altria subsidiary Philip Morris USA has the market expertise and infrastructure to ensure a successful launch.